Anumba D O, Robson S C, Boys R J, Ford G A
Department of Obstetrics and Gynaecology, University of Newcastle upon Tyne, Newcastle upon Tyne NE1 4LP, United Kingdom.
Am J Physiol. 1999 Aug;277(2):H848-54. doi: 10.1152/ajpheart.1999.277.2.H848.
We investigated the role of nitric oxide (NO) in the vascular resistance changes of normotensive and preeclamptic pregnancy. Forearm blood flow (FBF) responses to brachial artery infusion of N(G)-monomethyl-L-arginine (L-NMMA), an NO synthase inhibitor, and angiotensin II (ANG II), an NO-independent vasoconstrictor, were determined by plethysmography in 20 nonpregnant women, 20 normotensive primigravidae, and 15 primigravidae with untreated preeclampsia. In pregnant subjects, FBF was reduced to nonpregnancy levels by infusion of norepinephrine (NE), which was then coinfused with ANG II (2, 4, and 8 ng/min) and L-NMMA (200, 400, and 800 microgram/min) each for 5 min. In separate studies, responses to NE (20, 50, and 100 ng/min) were determined in 8 nonpregnant women, with FBF elevated to pregnancy levels by concomitant infusion of glyceryl trinitrate, and 10 pregnant women. Vasoconstrictor responses to L-NMMA were increased in pregnant compared with nonpregnant subjects [mean +/- SE summary measure (in arbitrary units): 60 +/- 7 vs. 89 +/- 8, respectively; P < 0.01], whereas responses to ANG II were blunted (125 +/- 11 vs. 79 +/- 7, respectively; P < 0.001). Compared with normotensive pregnant subjects, preeclamptic subjects had an enhanced response to ANG II (79 +/- 7 vs. 103 +/- 8, respectively; P < 0.05) but no difference in response to L-NMMA (89 +/- 8 vs. 73 +/- 10, respectively; P = 0.30). Responses to NE were similar in pregnant and nonpregnant subjects (110 +/- 20 vs. 95 +/- 33, respectively; P = 0.66). During the third trimester of pregnancy, forearm constrictor responses to L-NMMA are increased. The responses to NE are unchanged, whereas responses to ANG II are blunted. Increased NO activity contributes to the fall in peripheral resistance. In preeclampsia, forearm constrictor responses to ANG II but not L-NMMA are increased compared with those in normal pregnancy. Changes in vascular NO activity are unlikely to account for the increased vascular tone in this condition.
我们研究了一氧化氮(NO)在正常血压及先兆子痫孕妇血管阻力变化中的作用。通过体积描记法测定了20名未孕女性、20名正常血压初产妇以及15名未经治疗的先兆子痫初产妇,对肱动脉输注NO合酶抑制剂N(G)-单甲基-L-精氨酸(L-NMMA)和不依赖NO的血管收缩剂血管紧张素II(ANG II)时的前臂血流量(FBF)反应。在孕妇中,输注去甲肾上腺素(NE)可使FBF降至非孕期水平,随后分别与ANG II(2、4和8 ng/min)及L-NMMA(200、400和800 μg/min)共同输注5分钟。在单独的研究中,测定了8名未孕女性对NE(20、50和100 ng/min)的反应,通过同时输注硝酸甘油使FBF升高至孕期水平,以及10名孕妇对NE的反应。与未孕受试者相比,孕妇对L-NMMA的血管收缩反应增强[平均±标准误汇总测量值(任意单位):分别为60±7和89±8;P<0.01],而对ANG II的反应减弱(分别为125±11和79±7;P<0.001)。与正常血压孕妇相比,先兆子痫患者对ANG II的反应增强(分别为79±7和103±8;P<0.05),但对L-NMMA的反应无差异(分别为89±8和73±10;P = 0.30)。孕妇和未孕受试者对NE的反应相似(分别为110±20和95±33;P = 0.66)。在妊娠晚期,前臂对L-NMMA的收缩反应增强。对NE的反应无变化,而对ANG II的反应减弱。NO活性增加导致外周阻力下降。在先兆子痫中,与正常妊娠相比,前臂对ANG II而非L-NMMA的收缩反应增强。血管NO活性的变化不太可能解释这种情况下血管张力的增加。